Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of hyperglycemia with solute carrier family 39 member 5 (SLC39A5) inhibitors

Treatment of hyperglycemia with solute carrier family 39 member 5 (SLC39A5) inhibitors

US Patent 12083141 · Granted Sep 10, 2024

Estimated economic value: $97,825,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of decreased bone mineral density with zinc and ring finger 3 (ZNRF3) 2025
B4GALT1 variants and uses thereof2025
Non-human animals comprising a humanized coagulation factor 12 locus2025
Anti-factor XII/XIIa antibodies and uses thereof2024
Non-human animals comprising a humanized coagulation factor 12 locus2023
Treatment of decreased bone mineral density with zinc and ring finger 3 (ZNRF3) 2023
Treatment of increased lipid levels with sterol regulatory element binding trans2022
Treatment of increased lipid levels with sterol regulatory element binding prote2022
B4GALT1 cDNA variants and compositions comprising the same2020
Rodent model of steel syndrome2019
Polymerase inhibitor and method of using same2012
Cell fusion assays using fluorescence resonance energy transfer2006